Netherlands (NL)

Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015) Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Goehring G, et al. Journal article Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group (2015) Jordan S, Distler J, Maurer B, Huscher D, Van Laar JM, Allanore Y, Distler O Journal article Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV (2015) Saussele S, Krauss MP, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, et al. Journal article Ablation of CD8?(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice (2015) Legein B, Janssen EM, Theelen TL, Gijbels MJ, Walraven J, Klarquist JS, Hennies CM, et al. Journal article Characteristics of patients patch tested in the European Surveillance System on Contact Allergies (ESSCA) network, 2009-2012 (2015) Uter W, Gefeller O, Gimenez-Arnau A, Frosch P, Johansen JD, Schuttelaar ML, Rustemeyer T, et al. Journal article Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer (2015) Valentini V, Van Stiphout RGPM, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, et al. Journal article Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum (2015) Abu-Hayyeh S, Ovadia C, Lieu T, Jensen DD, Chambers J, Dixon PH, Lövgren-Sandblom A, et al. Journal article Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial (2015) Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, et al. Journal article Shared genetics underlying epidemiological association between endometriosis and ovarian cancer (2015) Lu Y, Cuellar-Partida G, Painter JN, Nyholt DR, Morris AP, Fasching PA, Hein A, et al. Journal article SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer (2015) Eichelberg C, Vervenne WL, De Santis M, Von Weikersthal LF, Goebell P, Lerchenmueller C, Zimmermann U, et al. Journal article